Zymeworks BC Inc
ZYME
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.11B
Close$
$-19.04
173% downside
Current Fair Value
173% downsideOvervalued by 173% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.11 Billion |
|---|---|
| Enterprise Value | $-144,815,634,968.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 1.15 |
| Outstanding Shares | 72,993,313 |
Return
| Return on Equity | -135.41% |
|---|---|
| Return on Assets | -27.41% |
| Return on Invested Capital | -31.87% |
Valuation & Multiples
| P/E Ratio | -14.19 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | -57580.77 |
| Enterprise Value to EBIT | 1.3 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.22 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$4.54 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$2.53
Average shareholder expectationRevenue Estimate
$212.49 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5137▲ 38.65% |
|---|---|
| Total Calls | 182,600▼ 58.96% |
| Total Puts | 93,800▲ 65.72% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 91.69%▼ 1.60% |
|---|---|
| Total Invested | $1.79B▲ 1.63% |
| Investors Holding | 206▼ 15.00% |
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani